|The MKI67 mki67 (Catalog #MBS1265096) is a Recombinant Protein produced from E Coli and is intended for research purposes only. The product is available for immediate purchase.
The MKI67 mki67 product has the following accession number(s) (GI #225543215) (NCBI Accession #NP_001139438.1) (Uniprot Accession #P46013). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful. The amino acid sequence is listed below:
NEKKPMKTSP EMDIQNPDDG ARKPIPRDKV TENKRCLRSA RQNESSQPKV AEESGGQKSA KVLMQ NQKGKGEAGN SDSMCLRSRK TKSQPAASTL ESKSVQRVTR SVKRCAENPK KAEDNVCVKK IRTRS HRDSEDI.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given recombinant protein. We\'ve tested the Recombinant human Antigen KI-67, partial with the following immunoassay(s):
Our knowledge of the role of proteins in cellular processes is continually evolving. Most proteins, including Antigen KI-67 are typically involved in one or more signaling pathways or biological processes. Professionally manufactured recombinant proteins are increasingly becoming essential and commonplace tools for elucidating new knowledge about the role of proteins in both health and disease.
Blood, Bone, Brain, Liver, Lung, Lymph, Lymph Node, Muscle, Skin, Vascular tissues are correlated with this protein. MKI67 also interacts with the following gene(s): BIRC5, BUB1, CCNA2, CDK1, KIF15, MKI67IP, TPX2. Adenocarcinoma, Adenoma, Breast Neoplasms, Carcinoma, Squamous Cell, Colorectal Neoplasms, Hyperplasia, Neoplasm Metastasis, Neoplasms, Neoplasms, Experimental, Nervous System Diseases are some of the diseases may be linked to Recombinant human Antigen KI-67, partial.